Back to Baird Financial Group, Inc. Baird Financial Group, Inc.

BRNSBRNS
Showing 8 of 15 quarters

Position history for Baird Financial Group, Inc.Baird Financial Group, Inc.'s holdings in BARINTHUS BIOTHERAPEUTICS PL

Baird Financial Group, Inc. holds 105,961 shares of BRNS (BARINTHUS BIOTHERAPEUTICS PL), worth $69,934 as of 2026-Q2. BRNS represents 0.0% of Baird Financial Group, Inc.'s portfolio.

Current Value

$69,934

Current Shares

105,961

Total Value Change

-$40,095

Total Shares Change

+13,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
105,961
0.0%
$69,9340.0%$0.66
0
2026-Q1
Unchanged
105,961
0.0%
$60,2920.0%$0.60
0
2025-Q4
Decreased
105,961
-1.4%
$74,1830.0%$0.68
0
2025-Q3
Decreased
107,461
-44.2%
$134,3260.0%$1.48
0
2025-Q2
Increased
192,461
+108.2%
$179,0080.0%$0.92
37
2025-Q1
Unchanged
92,461
0.0%
$89,9370.0%$1.05
0
2024-Q4
Unchanged
92,461
0.0%
$111,6930.0%$1.10
0
2024-Q3
Decreased
92,461
-65.5%
$110,0290.0%$1.18
0

Other major holders of BRNS: M&G Plc, TUDOR INVESTMENT CORP ET AL, Alphabet Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used